Question 31
A company is currently marketing an implantable orthopedic medical device. The R&D department is
planning to change the material used for the implant. The R&D department states that the change does
not impact the safety and effectiveness of the product. What action should the regulatory affairs
professional take FIRST?
planning to change the material used for the implant. The R&D department states that the change does
not impact the safety and effectiveness of the product. What action should the regulatory affairs
professional take FIRST?
Question 32
A company is developing a new medical device using innovative technology. Which of the following is
MOST critical in working with regulatory authorities?
MOST critical in working with regulatory authorities?
Question 33
What is the BEST approach to ensure that raw materials, services, and sub-contractors at the level of the
vendors comply with GMP requirements?
vendors comply with GMP requirements?
Question 34
Which of the following is an example of an acceptable statement for an advertisement of an approved
arthritis medication?
arthritis medication?
Question 35
According to the GHTF, which of the following is NOT an exemption rule when evaluating the decision to
report an adverse event?
report an adverse event?